13F-HR filed by Atlas Venture Life Science Advisors, LLC
Atlas Venture Life Science Advisors, LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-13, with 15 holding rows worth $645,631,364.
- Accession
- 0001104659-23-117225
- Filer
- CIK 1917529
- Filed
- 2023-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 15 entries on the cover page, a total value of $645,631,364 stated on the cover page (in dollars after the unit check, H1), rows summing to $645,631,364 with VALUE read as dollars as filed, 13F file number 028-22531. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DISC MEDICINE INC COM | 254604101 | Stock | 2,745,335 | $128,975,838 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 7,608,394 | $93,354,994 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 9,885,449 | $88,573,623 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 5,858,262 | $81,429,842 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 10,907,859 | $69,701,219 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 2,098,300 | $35,901,913 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 5,836,874 | $31,460,750 | dollars as filed | |
| GENERATION BIO CO | 37148K100 | COM | 8,279,484 | $31,379,244 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 2,039,249 | $27,672,609 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 5,018,178 | $21,728,711 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 359,251 | $18,170,915 | dollars as filed | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 4,541,381 | $6,993,727 | dollars as filed | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 2,759,344 | $5,822,216 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 236,979 | $3,239,503 | dollars as filed | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 1,013,438 | $1,226,260 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-117225 | this filing | 2023-11-13 | acceptance time not in the bulk data set |